Beverly Hills, CA, United States of America

Kazuko Matsuda

This inventor holds 29 USPTO granted patents and 22 published patent applications and 12 EPO patents, primarily in Cancer Treatment. Top assignees: Medicinova, Inc., Columbia University, Medicnova, Inc.. Active years: 2012-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuko Matsuda. Retrieved from https://idiyas.com/inventor/kazuko-matsuda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 22)

% Patents Active = 100.0

EPO Patents = 12 (Patent Applications = 24)

Average Co-Inventor Count = 1.8

ph-index = 4

Forward Citations = 70(Granted Patents)

Location History:

Beverly Hills, CA (US) (2012 - 2024)
La Jolla, CA (US) (2019 - 2024)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2012-2026

Loading Chart...

Areas of Expertise:

Glioblastoma Multiforme

Ibudilast

Neurodegenerative Disease

Cancer Metastasis

Triglyceride Synthesis

Ophthalmic Disease

Non-Alcoholic Fatty Liver

Irritable Bowel Syndrome

Asthma Treatment

Combination Therapy

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12721840 - Methods of treating glioblastoma multiforme using combination therapy (2026-09-01),

2. 12239620 - Methods to decrease triglyceride synthesis in the liver (2025-03-04),

3. 12213966 - Methods of reducing plasma level of macrophage migratory inhibitory factor in patients (2025-02-04),

4. 12171752 - Methods of treating post-COVID condition(s) (2024-12-24),

5. 12042485 - Methods of minimizing cancer metastasis (2024-07-23),

6. 12005049 - Methods of preventing cancer metastasis (2024-06-11),

7. 11944607 - Treatment of progressive neurodegenerative disease with ibudilast (2024-04-02),

8. 11925625 - Methods of treating chemical gas exposure (2024-03-12),

9. 11865214 - Ibudilast oral formulations and methods of using same (2024-01-09),

10. 11446283 - Methods and dosing regimens using ibudilast and a second agent for cancer therapy (2022-09-20),

11. 11278531 - Combination of ibudilast and riluzole and methods of using same (2022-03-22),

12. 11154540 - Methods of treating ophthalmic disease/disorder or injury with ibudilast (2021-10-26),

13. 11083713 - Treatment of progressive neurodegenerative disease with ibudilast (2021-08-10),

14. 10946071 - Combination of ibudilast and interferon-beta and methods of using same (2021-03-16),

15. 10744123 - Methods and dosing regimens using ibudilast and a second agent for cancer therapy (2020-08-18),

Title: Innovator Spotlight: Kazuko Matsuda - Pioneering Treatments for Neurodegenerative Diseases

Introduction: Kazuko Matsuda, a distinguished inventor based in Beverly Hills, CA, has made significant contributions to the field of healthcare with his groundbreaking patents. With a portfolio of 22 patents, Matsuda's innovative work focuses on developing treatments for progressive neurodegenerative diseases.

Latest Patents: Matsuda's recent patents showcase his dedication to advancing medical science. "Treatment of progressive neurodegenerative disease with ibudilast" and "Ibudilast oral formulations and methods of using same" exemplify his expertise in developing effective solutions for managing neurodegenerative conditions.

Career Highlights: Throughout his career, Matsuda has been associated with reputable companies such as Medicinova, Inc. His contributions to Medicinova, Inc. have played a crucial role in shaping the landscape of neurodegenerative disease treatment. By spearheading research and development initiatives, Matsuda has demonstrated his commitment to improving patient outcomes.

Collaborations: Matsuda has collaborated with industry experts including Michael E Kalafer and Richard E Gammans. Their combined efforts have led to the successful implementation of innovative treatment strategies for neurodegenerative diseases. Through collaborative endeavors, Matsuda has been able to leverage diverse skill sets and knowledge to drive impactful results.

Conclusion: Kazuko Matsuda's exceptional work in the field of healthcare innovation has significantly impacted the lives of individuals affected by neurodegenerative diseases. His relentless pursuit of novel treatment modalities underscores his dedication to pioneering advancements in medical science. Matsuda's patents and collaborations stand as a testament to his unwavering commitment to improving global health outcomes.

Profile summary based on public USPTO records.